We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ATRA market cap is 69.16M. The company's latest EPS is USD -2.2566 and P/E is -0.31.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.46M | 221k | 1.23M | 957k | 2.14M |
| Operating Income | -84.62M | -75.54M | -75.02M | -71.63M | -72.72M |
| Net Income | -84.09M | -76.27M | -74.77M | -71.11M | -69.8M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 20.34M | 63.57M |
| Operating Income | -237.11M | -295.68M | -309.05M | -340.46M | -280.51M |
| Net Income | -230.7M | -290.98M | -306.62M | -340.14M | -230M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 368.32M | 376.42M | 302.08M | 246.44M | 188.79M |
| Total Liabilities | 181.2M | 249.78M | 237.12M | 238.99M | 239.63M |
| Total Equity | 187.11M | 126.64M | 64.96M | 7.45M | -50.84M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 391.84M | 342.94M | 588.12M | 468.13M | 376.42M |
| Total Liabilities | 52.98M | 52.16M | 125.78M | 188.51M | 249.78M |
| Total Equity | 338.86M | 290.78M | 462.34M | 279.61M | 126.64M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -213.55M | -270.43M | -38.43M | -91.23M | -142.57M |
| Investing | 151.74M | 202.96M | -6.01M | 43.48M | 113.92M |
| Financing | 20.79M | 53.08M | 235k | 706k | 498k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -179.77M | -235.63M | -180.76M | -220.52M | -270.43M |
| Investing | -196.29M | 60.46M | -120.73M | 22.26M | 202.96M |
| Financing | 357.54M | 188.79M | 427.57M | 103.94M | 53.08M |
| Market Cap | 69.16M |
| Price to Earnings Ratio | -0.31 |
| Price to Sales Ratio | 1.12 |
| Price to Cash Ratio | 0.77 |
| Price to Book Ratio | 0.56 |
| Dividend Yield | - |
| Shares Outstanding | 101.92M |
| Average Volume (1 week) | 918.44k |
| Average Volume (1 Month) | 1.23M |
| 52 Week Change | -74.87% |
| 52 Week High | 3.08 |
| 52 Week Low | 0.1986 |
| Spread (Intraday) | 0.03 (4.67%) |
| Company Name | Atara Biotherapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.atarabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
